![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs15005-018-2728-1/MediaObjects/15005_2018_2728_Fig1_HTML.jpg)
Literatur
Launch-Pressekonferenz „Reagila®: Neuer Therapieansatz zur Behandlung der Schizophrenie“ 24.5.2018, Frankfurt am Main; Veranstalter: Recordati Pharma
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Freese, G. Cariprazin effektiv gegen Negativsymptomatik. InFo Neurologie 20, 52–53 (2018). https://doi.org/10.1007/s15005-018-2728-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15005-018-2728-1